Cancers | Free Full-Text | Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site
Cancers | Free Full-Text | Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site
Cytokeratin 7 marker validation. Cytokeratin 7 (CK7) demonstrates... | Download Scientific Diagram
Cytokeratin 7 expression as a predictor of an unfavorable prognosis in colorectal carcinoma | Scientific Reports
Cutaneous Metastases of Internal Tumors | Actas Dermo-Sifiliográficas
I Heart Pathology on Twitter: "Carcinomas generally demonstrate specific staining patterns based on the epithelial type and differentiation status. CK7 and CK20 stains may be helpful during the workup of a primary
CK7 expression associates with the location, differentiation, lymph node metastasis, and the Dukes' stage of primary colorectal cancers
CDX2, CK7 and CK20 staining in distant metastases of | Download Table
Cancers | Free Full-Text | Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site
I Heart Pathology on Twitter: "Carcinomas generally demonstrate specific staining patterns based on the epithelial type and differentiation status. CK7 and CK20 stains may be helpful during the workup of a primary
Late Consequences of Cancer and Its Treatment | Basicmedical Key
Diagnostic utility of vimentin, CD117, cytokeratin-7 and caveolin-1 in differentiation between clear cell renal cell carcinoma, chromophobe renal cell carcinoma and oncocytoma - ScienceDirect
Cytokeratin 7-negative and GATA binding protein 3-negative breast cancers: Clinicopathological features and prognostic significance | BMC Cancer | Full Text
Pathology Outlines - Cytokeratin 7 (CK7, K7)
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases | Modern Pathology
Cytokeratin 7 marker validation. Cytokeratin 7 (CK7) demonstrates... | Download Scientific Diagram
Immunohistochemical Profile for Unknown Primary Adenocarcinoma | PLOS ONE
Immunohistochemistry of Cancers | Oncohema Key
How to Diagnose and Treat a Cancer of Unknown Primary Site
Pathology Outlines - Cytokeratin 7 (CK7, K7)
Combined Immunohistochemistry for the “Three 7” Markers (CK7, CD117, and Claudin-7) Is Useful in the Diagnosis of Chromophobe Renal Cell Carcinoma and for the Exclusion of Mimics: Diagnostic Experience from a Single
CK7 expression associates with the location, differentiation, lymph node metastasis, and the Dukes' stage of primary colorectal cancers
Pathology Outlines - Cytokeratin 7 (CK7, K7)
The diagnostic algorithm for workup of a CK7−/CK20+ carcinoma. | Download Scientific Diagram
Metastatic carcinoma of unknown primary (Chapter 12) - Modern Immunohistochemistry
The diagnostic algorithm in female patients with CK7+/CK20− CUPs. | Download Scientific Diagram
Cancer of Unknown Primary Site - Hematology and Oncology - Harrisons Manual of Medicine, 18th Ed.
